MomsSpaghetti
1 week ago
LSD (lysergic acid diethylamide), like other Schedule I drugs, could potentially be developed into a medication without full legalization. Currently, LSD is illegal for all uses under Schedule I, meaning it is considered to have a high potential for abuse and no accepted medical use. However, clinical trials are underway to explore its therapeutic potential, particularly for conditions like anxiety, depression, and PTSD.
If these trials prove that LSD is safe (which they are proving) and effective for medical treatment, the FDA could approve a specific formulation of LSD as a prescription drug. In this case, it would still be tightly regulated and only available under medical supervision, such as through specialized clinics or doctors trained in its use. The broader ban on recreational use would likely remain in place, meaning LSD would not be fully legalized, just allowed in controlled, therapeutic contexts.
Jack Torrance
1 week ago
MM120 is a dissolving, oral medication prescribed by a doctor or psychologist and taken in the home or any other place the patient wants. There is no clinic session or physician monitoring. It's also not LSD, shrooms or ecstasy in their street drug forms. MM120 is a new molecule that is subject to the same toxicity and side effect testing as any other new medications, and it has already passed that scrutiny or it would not have made it to phase 3. Not sure, other than shorties bashing, why these stupid falsehoods are still being repeated.
bubka
2 weeks ago
I know the uber longs here donโt believe Iโm a long. I think Iโve been a long here a lot longer than most. Seriously, after all the pumping I just feel like anyone new to this stock doing due diligence might need a dose of reality.
Could this turn out to be successful? Absolutely! It can be hugely successful. But this is a developmental biotech. The risks here are real and thereโs always going to be bigger chance of failure due to bad financing, running out of money, trial failure, government intervention, etc.
These attacks started last December when Jack said we would get bought out for 30-40 billion dollars in 12 to 18 months. I joked and said โYeah, that or another reverse split!โ
The Uber longs lost their mind! Jack called me names and said he was going to put me on ignore. I guess he couldnโt stand missing out on my input because he answers all my posts. lol
I went through the reverse split just a couple of years ago and reinvested more just to watch it seemingly dwindle away everyday.
This stock is down another 25% in the less than 2 months since the last earnings report and has been severely diluted twice this year, once right before the ER. These are danger signals and Iโm going to mention here. I will get called bad names but I think it needs to be mentioned since all we get here is nonstop pumping!
Good luck to all longs, but just know there are no slam dunks in this level of investing. Only invest what you can afford to lose.
Jack Torrance
2 weeks ago
Odds at this stage of clinical trials, with great results thus far and a Breakthrough Therapy Designation, and with MindMed's backing and cash supply, are probably 80% or better. And if FDA approved, a $40B buyout would be a steal. What part are you having trouble understanding? Legitimately curious how someone could be this obtuse about a psyche medication that could potentially be prescribed to hundreds of millions of people worldwide. And it's not a one-time treatment. It would be a long-term treatment, like anti-depressants. Many, many sales to each patient.
Get. A. Clue.